HCmed partners with Pharos to market the Deepro vibrating mesh nebulizer in Indonesia

HCmed has announced that a partnership with pharmaceutical company Pharos Indonesia has led to approval for its Deepro vibrating mesh nebulizer from the Indonesian National Drug and Food Control Agency (BPOM), and the companies will now launch the Deepro device in Indonesia.

Earlier this year, HCmed announced that it had received a strategic investment from Vivo Capital’s PANDA Fund.

According to HCmed, “When HCmed was searching for a partner with the scale and ambition to bring Deepro to the next level and bring it to Indonesia, Pharos’s experience in key areas including certification acquirement, and direct channel pharmacy Century proved to be a great match.”

Read the HCmed press release.